Analysis of the Value of Alprostadil in the Treatment of Cerebral Infarction

Liyue ZHANG
DOI: https://doi.org/10.3969/j.issn.1674-9308.2015.32.100
2015-01-01
Abstract:Objective To investigate the value of alprostadil in the treatment of cerebral infarction. Methods 72 patients were randomly assigned into control group and observation group. The control group was Xuesetong treatment, observation group alprostadil treatment. Results The effective rate of the observation group was 86.11%, higher than that of the control group of 63.89%, The neurological function defect score in the observation group was (9.27±1.36), which was lower than that in the control group (15.34± 2.18), and the difference was statistically significant (P<0.05). Conclusion The effect of alprostadil in patients with cerebral infarction was signiifcantly high clinical value.
What problem does this paper attempt to address?